UNC Institute to Use InforSense Software for PGx Programs | GenomeWeb
NEW YORK (GenomeWeb News) - The University of North Carolina at Chapel Hill has licensed InforSense's workflow-based analytics platform for use in pharmacogenomics research projects, the company said yesterday.
 
The Institute of Pharmacogenomics and Individualized Therapy at UNC-CH will use the GenSense software in its efforts to develop "precise, effective treatment options for individual patients suffering from a wide range of conditions," InforSense said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.